cytarabine also known cytosine arabinoside arac chemotherapy medication used treat acute myeloid leukemia aml acute lymphocytic leukemia chronic myelogenous leukemia cml nonhodgkins given injection vein skin cerebrospinal liposomal formulation tentative evidence better outcomes lymphoma involving common side effects include bone marrow suppression vomiting diarrhea liver problems rash ulcer formation mouth serious side effects include loss consciousness lung disease allergic use pregnancy may harm cytarabine antimetabolite nucleoside analog families works blocking function dna cytarabine patented approved medical use world health organizations list essential cytarabine mainly used treatment acute myeloid leukaemia acute lymphocytic leukaemia backbone induction chemotherapy cytarabine also possesses antiviral activity used treatment generalised herpesvirus infection however cytarabine selective setting causes bone marrow suppression severe side effects therefore arac useful antiviral agent humans toxic cytarabine also used study nervous system control proliferation glial cells cultures amount glial cells important impact neuronscitation needed one unique toxicities cytarabine cerebellar toxicity given high doses may lead ataxia cytarabine may cause granulocytopenia impaired body defenses may lead infection thrombocytopenia may lead hemorrhagecitation needed toxicity pancreatitis leukopenia thrombocytopenia anemia gi disturbances stomatitis conjunctivitis pneumonitis fever dermatitis palmarplantar erythrodysesthesia rarely myelopathy reported high dose frequent intrathecal arac used protocols designated high dose cytarabine cause cerebral cerebellar dysfunction ocular toxicity pulmonary toxicity severe gi ulceration peripheral neuropathy rarecitation needed prevent side effects improve therapeutic efficiency various derivatives drugs including amino acid peptide fatty acid phosphates evaluated well different delivery cytosine arabinoside combines cytosine base arabinose sugar antimetabolic agent chemical name certain sponges similar compounds originally found use arabinoside sugars chemical cytosine arabinoside similar enough human deoxycytosine incorporated human dna different enough kills cell cytosine arabinoside interferes synthesis dna mode action due rapid conversion cytosine arabinoside triphosphate damages dna cell cycle holds phase synthesis dna rapidly dividing cells require dna replication mitosis therefore affected cytosine arabinoside also inhibits rna polymerases nucleotide reductase enzymes needed dna synthesis cytarabine first series cancer drugs altered sugar component nucleosides cancer drugs modify cytarabine often given continuous intravenous infusion follows biphasic elimination initial fast clearance rate followed slower rate cytarabine transported cell primarily monophosphorylated deoxycytidine kinase eventually active metabolite incorporated dna dna synthesiscitation needed several mechanisms resistance cytarabine rapidly deaminated cytidine deaminase serum inactive uracil derivative deaminated deoxycytidylate deaminase leading inactive substrate furthermore shown limit efficacy cytarabine efficacy used antiviral functions inhibiting viral dna cytarabine able inhibit herpesvirus vaccinia virus replication cells tissue culture however cytarabine treatment effective herpesvirus infection murine modelcitation needed mice aractp blocks memory consolidation shortterm memory context fear conditioning blockage memory consolidation proposed due inhibition aractp dna nonhomologous end joining thus transient dna breakage followed nonhomologous end joining appear necessary steps formation longterm memory eventcitation needed isolation arabinosecontaining nucleotides caribbean sponge cryptotheca crypta tectitethya crypta together realization compounds could act dna synthesis chain terminators led exploration novel nucleotides potential anticancer cytarabine first synthesized richard walwick walden roberts charles dekker university california approved united states food drug administration june initially marketed us upjohn trade name cytosarucitation needed also known arac arabinofuranosyl httpsenwikipediaorgwikicytarabine